Clinical Trial Update: Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating survival after neoadjuvant therapy in patients with resectable pancreatic cancer and risk factors. Status is unknown in the provided …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer Resectable

Snippet

Sponsor: Instituto de investigación e innovación biomédica de Cádiz | Conditions: Pancreatic Adenocarcinoma, Pancreatic Cancer Resectable | Phase 2, Phase 3 | Status: UNKNOWN